A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.

IF 2.6 4区 医学 Q2 HEALTH CARE SCIENCES & SERVICES
Milanne Maria Johanna Galekop, Josep Maria Del Bas, Philip C Calder, Carin A Uyl-De Groot, William Ken Redekop
{"title":"A health technology assessment of personalized nutrition interventions using the EUnetHTA HTA Core Model.","authors":"Milanne Maria Johanna Galekop, Josep Maria Del Bas, Philip C Calder, Carin A Uyl-De Groot, William Ken Redekop","doi":"10.1017/S0266462324000060","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Poor nutrition links to chronic diseases, emphasizing the need for optimized diets. The EU-funded project PREVENTOMICS, introduced personalized nutrition to address this. This study aims to perform a health technology assessment (HTA) comparing personalized nutrition interventions developed through this project, with non-personalized nutrition interventions (control) for people with normal weight, overweight, or obesity. The goal is to support decisions about further development and implementation of personalized nutrition.</p><p><strong>Methods: </strong>The PREVENTOMICS interventions were evaluated using the European Network for HTA Core Model, which includes a methodological framework that encompasses different domains for value assessment. Information was gathered via [1] different statistical analyses and modeling studies, [2] questions asked of project partners and, [3] other (un)published materials.</p><p><strong>Results: </strong>Clinical trials of PREVENTOMICS interventions demonstrated different body mass index changes compared to control; differences ranged from -0.80 to 0.20 kg/m<sup>2</sup>. Long-term outcome predictions showed generally improved health outcomes for the interventions; some appeared cost-effective (e.g., interventions in UK). Ethical concerns around health inequality and the lack of specific legal regulations for personalized nutrition interventions were identified. Choice modeling studies indicated openness to personalized nutrition interventions; decisions were primarily affected by intervention's price.</p><p><strong>Conclusions: </strong>PREVENTOMICS clinical trials have shown promising effectiveness with no major safety concerns, although uncertainties about effectiveness exist due to small samples (n=60-264) and short follow-ups (10-16 weeks). Larger, longer trials are needed for robust evidence before implementation could be considered. Among other considerations, developers should explore financing options and collaborate with policymakers to prevent exclusion of specific groups due to information shortages.</p>","PeriodicalId":14467,"journal":{"name":"International Journal of Technology Assessment in Health Care","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Technology Assessment in Health Care","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/S0266462324000060","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Poor nutrition links to chronic diseases, emphasizing the need for optimized diets. The EU-funded project PREVENTOMICS, introduced personalized nutrition to address this. This study aims to perform a health technology assessment (HTA) comparing personalized nutrition interventions developed through this project, with non-personalized nutrition interventions (control) for people with normal weight, overweight, or obesity. The goal is to support decisions about further development and implementation of personalized nutrition.

Methods: The PREVENTOMICS interventions were evaluated using the European Network for HTA Core Model, which includes a methodological framework that encompasses different domains for value assessment. Information was gathered via [1] different statistical analyses and modeling studies, [2] questions asked of project partners and, [3] other (un)published materials.

Results: Clinical trials of PREVENTOMICS interventions demonstrated different body mass index changes compared to control; differences ranged from -0.80 to 0.20 kg/m2. Long-term outcome predictions showed generally improved health outcomes for the interventions; some appeared cost-effective (e.g., interventions in UK). Ethical concerns around health inequality and the lack of specific legal regulations for personalized nutrition interventions were identified. Choice modeling studies indicated openness to personalized nutrition interventions; decisions were primarily affected by intervention's price.

Conclusions: PREVENTOMICS clinical trials have shown promising effectiveness with no major safety concerns, although uncertainties about effectiveness exist due to small samples (n=60-264) and short follow-ups (10-16 weeks). Larger, longer trials are needed for robust evidence before implementation could be considered. Among other considerations, developers should explore financing options and collaborate with policymakers to prevent exclusion of specific groups due to information shortages.

使用 EUnetHTA HTA 核心模型对个性化营养干预措施进行卫生技术评估。
目标:营养不良与慢性疾病有关,强调优化饮食的必要性。欧盟资助的 PREVENTOMICS 项目引入了个性化营养来解决这一问题。本研究旨在对通过该项目开发的个性化营养干预措施与非个性化营养干预措施(对照组)进行健康技术评估(HTA),对体重正常、超重或肥胖人群进行比较。目的是为进一步开发和实施个性化营养提供决策支持:方法:使用欧洲 HTA 核心模型网络对 PREVENTOMICS 干预措施进行评估,该模型包括一个方法框架,涵盖价值评估的不同领域。通过以下途径收集信息:[1] 不同的统计分析和建模研究;[2] 向项目合作伙伴提出的问题;[3] 其他(未)公布的资料:结果:PREVENTOMICS 干预措施的临床试验表明,与对照组相比,身体质量指数的变化各不相同;差异从-0.80 到 0.20 kg/m2 不等。长期结果预测显示,干预措施的健康结果普遍有所改善;有些干预措施似乎具有成本效益(如英国的干预措施)。与健康不平等有关的伦理问题以及个性化营养干预措施缺乏具体的法律规定也得到了确认。选择模型研究表明,人们对个性化营养干预持开放态度;决策主要受干预价格的影响:PREVENTOMICS临床试验显示了良好的效果,没有重大的安全问题,但由于样本较少(n=60-264)和随访时间较短(10-16周),效果还存在不确定性。在考虑实施之前,需要进行更大、更长时间的试验,以获得可靠的证据。除其他考虑因素外,开发人员还应探索融资方案,并与政策制定者合作,防止因信息不足而将特定群体排除在外。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Technology Assessment in Health Care
International Journal of Technology Assessment in Health Care 医学-公共卫生、环境卫生与职业卫生
CiteScore
4.40
自引率
15.60%
发文量
116
审稿时长
6-12 weeks
期刊介绍: International Journal of Technology Assessment in Health Care serves as a forum for the wide range of health policy makers and professionals interested in the economic, social, ethical, medical and public health implications of health technology. It covers the development, evaluation, diffusion and use of health technology, as well as its impact on the organization and management of health care systems and public health. In addition to general essays and research reports, regular columns on technology assessment reports and thematic sections are published.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信